GIA
INSY

Gargoyle Investment Advisor’s Insys Therapeutics, Inc. INSY Stock Holding History

Gargoyle Investment Advisor’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,617
Closed -$597K – 182
2015
Q2 		$597K Sell
16,617
-5,645
-25% -$176K 0.23% 130
2015
Q1 		$647K Buy
+22,262
New +$589K 0.24% 114

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gargoyle Investment Advisor's INSY Position: Q3 2015 in Review

Gargoyle Investment Advisor sold out of Insys Therapeutics, Inc. (INSY) in Q3 2015, closing a stake of 16,617 shares — an estimated $597K sold.

Gargoyle Investment Advisor first reported a position in INSY in Q1 2015 and held it in 2 quarters. The position peaked at $647K in Q1 2015. 145 funds tracked by Wall St. Rank hold INSY as of Q3 2015.

  • Gargoyle Investment Advisor reported no remaining Insys Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 16,617 Insys Therapeutics, Inc. shares in Q3 2015, an estimated $597K.
  • Gargoyle Investment Advisor first reported a position in Insys Therapeutics, Inc. in Q1 2015 and held it in 2 quarters.
  • Gargoyle Investment Advisor's Insys Therapeutics, Inc. position peaked at $647K in Q1 2015.
  • 145 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2015.

Based on Gargoyle Investment Advisor's 13F filing for Q3 2015, filed 9 Nov 2015.